OptimizeRx (OPRX) Competitors $17.66 -0.03 (-0.14%) As of 01:30 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OPRX vs. WLDN, UPBD, PRG, CRTO, TIXT, NEO, RDWR, IIIV, YEXT, and PRSUShould you be buying OptimizeRx stock or one of its competitors? The main competitors of OptimizeRx include Willdan Group (WLDN), Upbound Group (UPBD), Aaron's (PRG), Criteo (CRTO), Telus Digital (TIXT), NeoGenomics (NEO), Radware (RDWR), i3 Verticals (IIIV), Yext (YEXT), and Pursuit Attractions and Hospitality (PRSU). These companies are all part of the "business services" industry. OptimizeRx vs. Its Competitors Willdan Group Upbound Group Aaron's Criteo Telus Digital NeoGenomics Radware i3 Verticals Yext Pursuit Attractions and Hospitality Willdan Group (NASDAQ:WLDN) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability. Which has higher valuation and earnings, WLDN or OPRX? Willdan Group has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Willdan Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWilldan Group$565.80M2.39$22.57M$2.3938.53OptimizeRx$104.75M3.12-$18.66M-$0.54-32.61 Do insiders & institutionals hold more shares of WLDN or OPRX? 72.3% of Willdan Group shares are held by institutional investors. Comparatively, 76.5% of OptimizeRx shares are held by institutional investors. 8.6% of Willdan Group shares are held by insiders. Comparatively, 5.6% of OptimizeRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media prefer WLDN or OPRX? In the previous week, Willdan Group had 7 more articles in the media than OptimizeRx. MarketBeat recorded 8 mentions for Willdan Group and 1 mentions for OptimizeRx. OptimizeRx's average media sentiment score of 1.01 beat Willdan Group's score of 0.29 indicating that OptimizeRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Willdan Group 0 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OptimizeRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is WLDN or OPRX more profitable? Willdan Group has a net margin of 5.60% compared to OptimizeRx's net margin of -9.42%. Willdan Group's return on equity of 18.60% beat OptimizeRx's return on equity.Company Net Margins Return on Equity Return on Assets Willdan Group5.60% 18.60% 9.65% OptimizeRx -9.42%4.50%3.12% Do analysts prefer WLDN or OPRX? Willdan Group currently has a consensus target price of $111.50, suggesting a potential upside of 21.09%. OptimizeRx has a consensus target price of $11.81, suggesting a potential downside of 32.92%. Given Willdan Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Willdan Group is more favorable than OptimizeRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Willdan Group 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25OptimizeRx 1 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.69 Which has more volatility & risk, WLDN or OPRX? Willdan Group has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.25, indicating that its stock price is 25% more volatile than the S&P 500. SummaryWilldan Group beats OptimizeRx on 11 of the 15 factors compared between the two stocks. Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OPRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPRX vs. The Competition Export to ExcelMetricOptimizeRxCOMP IndustryComputer SectorNASDAQ ExchangeMarket Cap$327.77M$179.18B$32.51B$10.53BDividend YieldN/A1.22%3.16%4.67%P/E Ratio-32.6930.82496.2626.88Price / Sales3.126.792,025.79184.02Price / CashN/A27.1135.0131.10Price / Book2.779.457.506.67Net Income-$18.66M$4.39B$819.01M$276.44M7 Day Performance-14.10%-0.86%2.13%3.10%1 Month Performance-6.43%1.81%10.91%10.19%1 Year Performance138.94%6.62%24,144.34%40.32% OptimizeRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPRXOptimizeRx1.4412 of 5 stars$17.66-0.1%$11.81-33.1%+134.5%$327.49M$104.75M-32.67100Positive NewsWLDNWilldan Group4.6026 of 5 stars$90.86-0.4%$111.50+22.7%+117.5%$1.34B$565.80M38.021,761News CoverageAnalyst ForecastUPBDUpbound Group4.6326 of 5 stars$22.03-3.1%$37.25+69.1%-26.0%$1.32B$4.32B12.3811,970PRGAaron's4.3127 of 5 stars$31.46-1.9%$41.00+30.3%-34.3%$1.27B$2.46B6.221,403Positive NewsCRTOCriteo3.7985 of 5 stars$21.43-0.6%$40.00+86.7%-46.2%$1.25B$1.93B8.973,507News CoverageTIXTTelus Digital2.5332 of 5 stars$4.49+0.2%$3.93-12.4%+19.7%$1.24B$2.66B-3.2378,879NEONeoGenomics2.9929 of 5 stars$9.10flat$12.56+38.0%-34.7%$1.18B$660.57M-11.232,200RDWRRadware4.2831 of 5 stars$27.56+1.7%$32.50+17.9%+23.0%$1.16B$288.81M86.131,208News CoverageIIIVi3 Verticals4.2579 of 5 stars$32.92-0.4%$34.33+4.3%+49.9%$1.07B$229.92M6.311,480YEXTYext1.9693 of 5 stars$8.41-0.1%$9.44+12.2%+25.1%$1.04B$420.96M-70.081,150Positive NewsPRSUPursuit Attractions and Hospitality2.0236 of 5 stars$36.42+2.0%$29.67-18.5%N/A$1.01B$366.49M3.151,500Positive News Related Companies and Tools Related Companies Willdan Group Alternatives Upbound Group Alternatives Aaron's Alternatives Criteo Alternatives Telus Digital Alternatives NeoGenomics Alternatives Radware Alternatives i3 Verticals Alternatives Yext Alternatives Pursuit Attractions and Hospitality Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OPRX) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
